SYMPOSIUM PRESENTERS

Dan Arnold, MD, University of Louisville

Peter Bulova, MD, Associate Professor of Medicine; Co-Director, Magee Center for Women with Disabilities; Director, University of Pittsburgh Adult Down Syndrome Center

George Capone, MD, Director, Kennedy Krieger Institute's Down Syndrome Clinic and Research Center

Angelo Carfì, MD, Fondazione Policlinico Gemelli IRCCS

Celanie Christensen, MD, MS, Assistant Professor of Clinical Pediatrics and Neurology, Indiana University School of Medicine

Steven Ciciora, MD, Nationwide Children's Hospital/The Ohio State University College of Medicine

Terri Couwenhoven, MS, Clinic Coordinator, Children's Hospital of Wisconsin-Down Syndrome Clinic

Joaquin Espinosa, PhD, Executive Director, Linda Crnic Institute for Down Syndrome

Margaret Froehlke, RN, BSN

Anke Huels, PhD, Rollins School of Public Health, Emory University

David Lohr, MD, University of Louisville

Helen Milligan, PT, MPT, Physical Therapist, Physical Therapy Department, Children's Hospital of Philadelphia

Andrew Nowalk, MD, PhD, Associate Professor of Pediatrics, UPMC Children's Hospital of Pittsburgh

Melissa Parisi, MD, PhD, National Institutes of Health (NIH)

Lina Patel, PsyD, Director of Psychology at the Sie Center for Down Syndrome, Children's Hospital Colorado; Assistant Professor, University of Colorado School of Medicine

Albert Pless, Jr., MS, Massachusetts General Hospital

Tilman Rohrer, MD, Saarland University Medical Center

Stephanie Santoro, MD, Massachusetts General Hospital

Noemi Spinazzi, MD, Medical Director, Down Syndrome Clinic at UCSF Benoiff Children's Hospital Oakland; Assistant Clinical Professor, UCSF School of Medicine

Mary Stephens, MD, MPH, FAAFP, FAADM, Medical Director, Jefferson Continuing Care Program (JCCP), Associate Professor, Family and Community Medicine

Diletta Valentini, MD, Bambino Gesù Children's Hospital

Kishore Vellody, MD, Professor of Pediatrics; Medical Director of Down Syndrome Center of Pennsylvania; University of Pittsburgh School of Medicine

Nicole White, PhD, MBA, Cincinnati Children's Hospital Medical Center

Amber Wright, MSN, CPNP, PMHS, Oregon Health and Sciences University - IDD/CDRC - Eugene

Bethany Ziss, MD, AHN Pediatrics

SYMPOSIUM PLANNING COMMITTEE 

Nicole Baumer, MD, MEd, Director, Boston Children's Hospital Down Syndrome Program

Gabriela Eguiarte, MD, Pediatrician, Angeles Pedregal Hospital, Mexico

Katie Frank, PhD, OTR/L, Annual Symposium Committee Co-Chair; Occupational Therapist III, Advocate Medical Group Adult Down Syndrome Center

Amy Lyle, MSSW, Clinic Coordinator, Waisman Down Syndrome Clinic, University of Wisconsin-Madison

Andrew McCormick, MD, Director, Healthy Transitions Program, Down Syndrome Center of Western Pennsylvania; Associate Professor of Pediatrics, University of Pittsburgh School of Medicine

Lina Patel, PsyD, Director of Psychology at the Sie Center for Down Syndrome, Children's Hospital Colorado; Assistant Professor, University of Colorado School of Medicine

Emilie Perkins, Director of Client and Conference Services, Raybourn Group International

Moya Peterson, PhD, APRN, FNP-BC, Adults with Down Syndrome Specialty Clinic, Department of Family Medicine and Community Health, University of Kansas Medical Center

Noemi Spinazzi, MD, Medical Director, Down Syndrome Clinic at UCSF Benoiff Children's Hospital Oakland; Assistant Clinical Professor, UCSF School of Medicine

Maria Stanley, MD, FAAP, Annual Symposium Committee Co-Chair; Clinical Professor of Pediatrics, University of Wisconsin School of Medicine and Public Health; Medical Director, Waisman Center; Director, Down Syndrome Clinic

Nicole White, PhD, MBA, Cincinnati Children's Hospital Medical Center

Disclosure for the Annual Symposium on June 17:

Policy on Disclosure

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.